Institut Curie operates as a dual-mission organization—a 3,000-person research foundation pairing one of Europe's largest cancer research centers with two hospital systems, founded on Marie Curie's original 1909 model. The tech stack is standard office/clinical infrastructure (SharePoint, Teams, PACS imaging), with no adopting/replacing signals; hiring is anchored in healthcare and research roles but includes friction points (HR process efficiency, international onboarding, staff management) typical of scaling clinical-academic hybrids managing both discovery and patient care.
Institut Curie is a nonprofit research foundation and hospital system headquartered in Paris, France, with roughly 3,000 researchers, clinicians, nurses, technicians, and support staff. The organization combines basic, translational, and clinical cancer research with reference-level hospital services—particularly in breast cancer, pediatric malignancies, eye tumors, and emerging areas like pancreatic and lung cancer. The clinical hospital network operates alongside a dedicated research center, enabling direct translation of laboratory findings into treatment protocols. All operations are based in France.
Institut Curie conducts multidisciplinary cancer research across basic, translational, and clinical pathways. Active projects include novel inhibitors of homologous recombination, 3D image reconstruction algorithms, single-molecule imaging in the nucleus, and high-content screening at the Biophenics imaging platform.
Institut Curie's hospital network operates as a reference center for breast cancer, pediatric malignancies, eye tumors, sarcomas, pancreatic cancer, and lung cancer, supported by its integrated research infrastructure.
Other companies in the same industry, closest in size